Docoh
Loading...

GLPG Galapagos

347 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
6-K
GLPG Galapagos NV
13 Jan 22
Galapagos creates new subscription right plan
4:32pm
6-K
GLPG Galapagos NV
10 Jan 22
Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference
3:12pm
6-K
GLPG Galapagos NV
6 Dec 21
Current report (foreign)
6:00am
6-K
GLPG Galapagos NV
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
GLPG Galapagos NV
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
GLPG Galapagos NV
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
SC 13D
Van Herk Investments B.V.
2 Nov 21
GALAPAGOS / VAN HERK INVESTMENTS B.V. ownership change
4:44pm
S-8
GLPG Galapagos NV
26 Oct 21
Registration of securities for employees
4:07pm
6-K
GLPG Galapagos NV
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
GLPG Galapagos NV
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
GLPG Galapagos NV
20 Sep 21
Current report (foreign)
8:00pm
6-K
GLPG Galapagos NV
20 Sep 21
Current report (foreign)
9:26am
6-K
GLPG Galapagos NV
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
GLPG Galapagos NV
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
GLPG Galapagos NV
14 Jul 21
Current report (foreign)
5:27pm
6-K
GLPG Galapagos NV
14 Jul 21
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
5:13pm
6-K
GLPG Galapagos NV
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
GLPG Galapagos NV
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
GLPG Galapagos NV
8 Jun 21
Current report (foreign)
6:14am
6-K
GLPG Galapagos NV
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am